Press & Statements

Pfizer Back To “Business As Normal”

Nov 16, 2018

For Immediate Release November 16, 2018 Contact: Lauren Blair (201) 213-5004 Read More

CSRxP Statement on 2018 Midterm Election Results

Nov 7, 2018

Out-of-control drug prices was a prominent issue on the campaign trail. With Read More

CSRxP Statement On The Trump Administration’s Proposal To Change Medicare Drug Prices

Oct 25, 2018

For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies Read More

CSRxP Statement On PhRMA’s DTC Advertising Announcement

Oct 15, 2018

The Campaign for Sustainable Rx Pricing (CSRxP) issued the following statement Read More

CSRxP Statement On HHS DTC Advertising Announcement

Oct 15, 2018

CSRxP issued the following statement in response to the U.S. Department of Read More

Congress Rejects Big Pharma Bailout

Sep 26, 2018

Defeat For Price-Gouging Drug Manufacturers; Victory For Taxpayers & Read More

CSRxP Urges Congress to Stop Big Pharma’s $4 Billion Bailout

Sep 25, 2018

Washington, D.C. – Today the Campaign for Sustainable Rx Pricing Read More

CSRxP Statement on Potential Big Pharma Bailout

Sep 21, 2018

“Only Big Pharma would use bipartisan opioid legislation as another Read More

CSRxP Statement On Exclusion Of Big Pharma Accountability Amendment In Appropriations Bill

Sep 13, 2018

House Misses Bipartisan Opportunity To Hold Big Pharma Accountable Read More

CSRxP Urges House Members To Maintain Transparency Provision In Senate-Passed Appropriations Bill

Aug 29, 2018

CSRxP-Supported Policy Enables HHS To Require Drug Price Disclosure In Read More